Lv3
220 积分 2025-12-30 加入
Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer
15天前
已完结
Linker Manipulation with Beta 3 ‐Amino Acids Potentiates the Efficacy and Safety of PSMA Radiopharmaceuticals
19天前
已完结
Development and Evaluation of [(68)Ga]Ga-DOTA-BT1718: A Novel Imaging Agent Targeting MT1-MMP for Malignant Tumor Diagnosis
2个月前
已完结
皖公网安备34019202002308
